Emergencias
-
To perform an in-depth analysis of the process of transferring patients from an emergency department (ED) to other areas inside a hospital and identify possible points of failure and risk so that strategies for improvement can be developed. ⋯ The FMEA method helped the group to identify points when there is risk of failure during patient transfers and to define ways to improve patient safety.
-
To analyze factors related to the use of digoxin to treat patients with acute heart failure (AHF) in emergency departments (EDs) and the impact of digoxin treatment on short-term outcomes. ⋯ Digoxin continues to be used in one out of ten ED patients who are not already on long-term treatment with the drug. Digoxin use is associated with cardiac decompensation triggered by atrial fibrillation with rapid ventricular response, younger age, women, and patients with better initial NYHA function status but possibly more severe decompensation. Digoxin use leads to a longer ED stay but is safe, as it is not associated with need for admission, prolonged hospitalization, or short-term mortality.
-
In the article "Emergency department management of atrial fibrillation: 2023 consensus from the Spanish Society of Emergency Medicine (SEMES), the Spanish Society of Cardiology (SEC), and the Spanish Society of Thrombosis and Hemostasis (SETH)" published in Volume 35, Issue 5, October 2023, October 2023, there were some errors that are detailed and corrected below: On page 361, Figure 1, this originally published figure contained errors and would be replaced by the one attached below. On page 363, Table 1, in the column for rivaroxaban dose, where it says 20 mg/12 h, it should read 20 mg/24 h. On page 365, Figure 3, this originally published figure contained errors and would be replaced by the figure below.